The Structural Genomics Consortium is a not-for-profit company that aims to determine the three dimensional structures of proteins of medical relevance, and place them in the public domain without restriction. The project has over four hundred structures in its Protein Data Bank and operates from laboratories at the Universities of Toronto and Oxford.  The Canadian and British sponsor the Consortium from both the public and private sectors, including the Wellcome Trust, GlaxoSmithKline and Genome Canada. {{LINK_LABEL_GO_TO_WEBSITE}}

Related topics